These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 20091560)
21. Type I interferons for induction of remission in ulcerative colitis. Seow CH; Benchimol EI; Griffiths AM; Steinhart AH Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167 [TBL] [Abstract][Full Text] [Related]
22. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis. Jairath V; Zou GY; Parker CE; MacDonald JK; AlAmeel T; Al Beshir M; Almadi MA; Al-Taweel T; Atkinson NS; Biswas S; Chapman T; Dulai PS; Glaire MA; Hoekman DR; Koutsoumpas A; Minas E; Mosli MH; Samaan M; Khanna R; Travis S; D'Haens G; Sandborn WJ; Feagan BG Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011572. PubMed ID: 28886205 [TBL] [Abstract][Full Text] [Related]
23. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Chande N; Wang Y; McDonald JW; MacDonald JK Cochrane Database Syst Rev; 2015 Aug; 8(8):CD006774. PubMed ID: 35658167 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314 [TBL] [Abstract][Full Text] [Related]
26. Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis. Li W; Zhang ZM; Jiang XL Colorectal Dis; 2016 Jul; 18(7):O214-23. PubMed ID: 27214762 [TBL] [Abstract][Full Text] [Related]
27. Methotrexate for maintenance of remission in ulcerative colitis. Wang Y; MacDonald JK; Vandermeer B; Griffiths AM; El-Matary W Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007560. PubMed ID: 26263042 [TBL] [Abstract][Full Text] [Related]
28. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Marshall JK; Irvine EJ Aliment Pharmacol Ther; 1995 Jun; 9(3):293-300. PubMed ID: 7654892 [TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses. Nguyen NH; Fumery M; Dulai PS; Prokop LJ; Sandborn WJ; Murad MH; Singh S Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):742-753. PubMed ID: 30122356 [TBL] [Abstract][Full Text] [Related]
30. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Marshall JK; Irvine EJ Gut; 1997 Jun; 40(6):775-81. PubMed ID: 9245932 [TBL] [Abstract][Full Text] [Related]
31. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542 [TBL] [Abstract][Full Text] [Related]
32. Transdermal nicotine for induction of remission in ulcerative colitis. McGrath J; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126 [TBL] [Abstract][Full Text] [Related]
33. Type I interferons for induction of remission in ulcerative colitis. Wang Y; MacDonald JK; Benchimol EI; Griffiths AM; Steinhart AH; Panaccione R; Seow CH Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006790. PubMed ID: 26368001 [TBL] [Abstract][Full Text] [Related]
34. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis. Ford AC; Khan KJ; Achkar JP; Moayyedi P Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446 [TBL] [Abstract][Full Text] [Related]
36. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Bosworth BP; Sandborn WJ; Rubin DT; Harper JR Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045 [TBL] [Abstract][Full Text] [Related]
37. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Akobeng AK; Gardener E Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913 [TBL] [Abstract][Full Text] [Related]
38. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Lawson MM; Thomas AG; Akobeng AK Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078 [TBL] [Abstract][Full Text] [Related]
39. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960 [TBL] [Abstract][Full Text] [Related]